Answers are grounded in this paper and cite their sources.
This figure shows how the integration of AI, in silico methods, and CRISPR technology revolutionizes cancer drug repurposing, enabling efficient discovery and validation of repurposed drugs, accelerating the development of novel cancer therapies.
No takes yet. Share an insight, caveat, or question.
Gamal et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: